Portland Veterinarian Diverted Controlled Substances, Replaced with Saline

What Happened

Dr. Brenda Brown-Carlson, a veterinarian practicing at two clinics in Portland, Oregon, diverted hydromorphone (Schedule II), buprenorphine (Schedule III), and butorphanol (Schedule IV) for personal use and refilled the vials with saline, compromising the pain treatment of more than 200 animals.

Video surveillance at one of the clinics captured Brown-Carlson diverting controlled substances and refilling the vials with saline. When initially confronted, she denied the conduct. She later admitted it. The saline-substituted vials were used in clinical care, meaning animals received ineffective pain control — a direct patient-safety consequence of the tampering.

Brown-Carlson pleaded guilty to tampering with drug records, computer crimes, and attempted animal neglect. She was sentenced on January 13, 2026 to 60 months of supervised probation. Her DEA registration was surrendered as part of the resolution.

What Went Wrong

A licensed veterinarian was able to divert controlled substances across multiple drug schedules at two separate clinics over a period sufficient to affect more than 200 animals before being caught on video surveillance. Key failures include:

• Tampered vials returned to active clinical use. Saline-substituted vials of hydromorphone, buprenorphine, and butorphanol were administered to animals, directly causing inadequate analgesia. The harm was not hypothetical — the substitution had clinical consequences for patients in the care of the clinics.
• Multi-site diversion went undetected across two clinics. The conduct occurred at two locations, suggesting controlled substance accountability processes were not strong enough at either site to detect the discrepancy independently.
• Denial as a response to confrontation. When initially confronted, Brown-Carlson denied the conduct. This pattern — initial denial followed by admission only after evidence was presented — is common in diversion cases and underscores the importance of documentation and evidence preservation before confronting a subject.
• Detection depended on video surveillance, not inventory controls. The case was resolved by surveillance footage, not by a reconciliation or product integrity check. Had the tampering not been captured on video, the diversion might have continued longer.
• Veterinary setting had fewer mandatory DEA accountability structures. Veterinary practices are subject to DEA registration and recordkeeping requirements, but may not have the same internal audit infrastructure as hospital or pharmacy settings, creating gaps that a diverting practitioner can exploit.

How It Could Have Been Prevented

• Inspect controlled substance vials for tamper evidence — puncture marks, altered fill volume, changes in solution clarity — before every administration, and train all clinical staff on what to look for.
• Reconcile controlled substance withdrawals against documented procedures and patient records on a per-day or per-procedure basis, investigating any unaccounted-for quantity before the next clinical day begins.
• Require witnessed waste or return for any partially used controlled substance vial, with dual sign-off and immediate documentation in the patient record or procedure log.
• Apply the same controlled substance accountability standards across all clinic locations — including secondary or satellite sites — rather than centralizing oversight only at a primary location.
• Implement behavioral surveillance for practitioners with sole or unobserved access to controlled substance storage: unusual access frequency, withdrawal without a corresponding procedure, or patterns inconsistent with patient caseload.
• Preserve documentation and video evidence before confronting a suspected diverter, and involve legal counsel and regulatory counsel in the investigation to ensure proper handling of admissions and reporting obligations.

Related Guidance

• 15 Red Flags of Drug Diversion — Behavioral indicators that a practitioner may be diverting controlled substances, including patterns common in veterinary and outpatient settings.
• Investigation Playbook — How to conduct an internal diversion investigation, preserve evidence, and manage confrontation appropriately.
• Policy Templates — Controlled substance handling, vial inspection, and waste documentation policy templates adaptable to clinical settings.
• Diversion Trends — Current enforcement trends including tampering cases and the growing use of video surveillance in diversion investigations.